God is our Guide  Number 1 site for helping reverse diseases on Planet Earth
 

CIDPUSA.ORG

 
Home
Diagnosis
Treatment
Pathology
Variants
CIDP info
Fibromyalgia
IVIG
Anti-inflammatory Diet
Burning  Feet Home
Services Page
Chronic Fatigue
Autoimmune diseases
Prognosis
Bible healing
Celiac disease

Coconut oil Benefits

Brain Cancer ZAPPER

Killing Cancer

Regan Cancer Cure

Berry KiLLS CANCER

zapper

Cancer therapy

Cancer cure

Vitamins and cancer

Cancer Prevention

Broccoli CANCER

B-17 cancer

 Dementia and exercise

 Exercise and weight loss

  Sleep and stay fit

Bird Flu

Cancer killer cells

Oils for health

Green tea      

Women over 60

 Bees disappearance

Hypoparathroidism

Mercury in makeup

    Toxic Lipstick

Toxic Baby products

Infants  and women omega-3

 Selenium

Basil

Bay leaves

Eliminate insulin implants

Sugar treatment

Heart FAILURE

Irregular periods

cancer survivor

New Vaccine

 Vaginal problems

Vasculitis

Vinegar Benefits

GERD

MSG buster

Takayasu arteritis

  Killing cancer with high PH   CIDPUSA Foundation

   alternatives treatment of autoimmune disease read our e-book 

Special GoogleHealth Search

    The Cs-treatment was given in conjunction of other supportive compounds under diet control in addition to the utilization of specific compounds to produce adequate circulation and oxygenation.  According to individual cases CsCl was given at daily dosages of 6 to 9 grams in 3 equally divided doses, with vitamin A-emulsion (100,000 to 300,000 U), vitamin C (4 to 30 grams), zinc (80 to 100 mg) selenium (600 to 1,200 mcg) and amygdalin (1,500 mg) in addition to other supplementations according to the specific needs of the patient.  The diet consisted mainly of whole grains, vegetables, linolenic acid rich oils (linseed, walnut, soy, wheat germ) and other supplemental food.  To increase efficiency of the treatment and improve the circulation and oxygenation, the patients received the chelating agent EDTA, dimethylsulfoxide (DMSO) and also a combination of vitamins, K and Mg salts.

Results

    Table 1 summarizes the results of the Cs-treatment of 50 cancer patients studied over 3 years.  They had generalized metastatic disease, except for 3 patients.  Initial death occurrences for the initial 2 week treatment was in the same order and magnitude of these recorded for the 12 month period.   The percent of survival of breast, colon, prostate, pancreas, and lung cancer accounted to approximately, 50% recovery which was higher than that noted for liver cancer and the lymphoma patients treated.  An overall 50% recovery from cancer by the Cs-therapy was determined in the 50 patients treated.  Data from the autopsy made indicated the absence of tumors in patient dying within 14 days of the Cs-treatment.  One of the most striking effects of the treatment was the disappearance  of pain in all patients within 1 to 3 days after initiation of the Cs-therapy.  

    These studies were performed under my direction, initiated in April, 1981.  Twenty-eight patients were initially treated with CsCl between April, 1981 to October, 1982.  They were subjected to various cancer therapies, e.g., surgery, radiation, and chemotherapy, and were considered terminal cases with metastatic disease except for 3 patients who were not previously treated.  Three patients were comatose at the time of the Cs treatment.  Thirteen patients died within less than 2 weeks of treatment.  Each patient showed a reduction in tumor mass by the Cs-treatment.  Of the breast cancer patients, the most impressive effect was seen in a female patient who was comatose at the beginning of the Cs-treatment and was considered a terminal case.  The Cs-therapy, with other ingredients used, was immediately instituted by nasogastric route because there was no cooperation from the patient.   The daily CsCl dose given amounted to 30 grams, 10 grams given 3 times daily.  The patient was able to leave after 5 days of treatment.  However the patient's fall on the floor resulted in complications, i.e., fracture of the neck, and death.  The autopsy revealed that the cancer metastasis had essentially eaten away her hip bone causing this tragic accident.  The autopsy performed also showed the presence of very little cancer tissue.

     The next most frequent cancer treated was of unknown primary.  Treatment of 8 cases showed a death rate of 2 within 14 days of treatment and an additional 2 deaths within 12 months while 4 of the patients are still living.  In one case, an autopsy was made in a patient after one week of Cs-treatment and showed a complete disappearance of the cancer.  There were 7 cases of colon cancer patients who were treated with CsCl.  Two of these patients died within 14 days, one of the patients had previous massive chemotherapy, and little time was available to restore her metabolic condition.  The previous existing infiltration of the abdominal wall disappeared.  However, no consent was given for an autopsy.

     In one lymphoma case the patient displayed an unusually large abdomen  which was hard and he weighed approximately 250 pounds.  The massively enlarged abdomen began to decline in volume, i.e., a loss of approximately 120 pounds of body weight was noted after 3 months of the Cs- therapy.  The spleen which was originally maximally enlarged and reaching into the pelvis was reduced to almost normal size.  The liver position was down to about the level of the umbilicus and was also reduced to normal size in 3 months.  The patient is still living after 3 years after his discharge.  Unfortunately, there is no follow-p on this patient and he is being maintained on chemotherapy.

continued to next page